Duragesic Patch Attorney and Fentanyl Lawyer for Duragesic Recall

Duragesic® Defective Drug Lawyers

The law firm of MacDonald Rothweiler Eisenberg L.L.P. was established to provide aggressive legal representation to individuals and their loved ones who have suffered serious injury or death. We have earned a reputation among the foremost personal injury attorneys in the Boston and Philadelphia areas as one of the most successful and talented plaintiff's firms. With over 100 years of combined experience, our renowned attorneys have achieved record-breaking results for our clients in cases against large insurance and other Fortune 500 companies. Our legal team delivers the expertise, personal attention, and results our valued clients deserve throughout their important case. Our offices are located in Boston, Massachusetts and Philadelphia, Pennsylvania and Cherry Hill, New Jersey. MacDonald Rothweiler Eisenberg L.L.P. receives client referrals from many respected attorneys, who recognize us as among the most accomplished and professional legal advocates in the pharmaceutical products, personal injury, mass tort, medical malpractice, automobile "crashworthiness" and complex product liability fields.

FENTANYL PATCH UPDATE - AUGUST 27, 2009 - After years of litigation and FDA scrutiny, a subsidiary of Johnson & Johnson, Ortho-McNeil, has removed the Duragesic reservoir pain patch from the market. The Duragesic reservoir pain patch is one of Johnson & Johnson's top-selling pharmaceutical drugs with over $2 billion in sales for 2005 alone. However, the reservoir design may leak which has led to numerous recalls over the past years. Fentanyl is 100 times more potent than morphine and so a leaking patch can be fatal. Our Fentanyl Patch Litigation Team has successfully litigated wrongful death cases throughout the United States fighting on behalf of the families whose loved ones died from leaking reservoir patches. The FDA has examined more than 120 deaths that could have been caused by the dangerous reservoir patch. After nineteen years of selling the reservoir patch to the general public, Johnson & Johnson has jus recently replaced the reservoir design with it's "new" design which they allege does not leak. Johnson & Johnson's "new design" is not new. J&J has used the "new" patch technology in Europe for years. Additionally, generic fentanyl patch manufactures have used the "new" patch technology in the United States for years. If a loved one has died and you suspect that their death may be due to a leaking fentanyl patch, contact our law firm immediately to speak with an attorney from our Fentanyl Patch Litigation Team.

Duragesic® Pain Patch Recall

August 7, 2009 - Watson Pharmaceuticals has recalled one lot of 100 mcg/hr Fentanyl Transdermal System patches with the lot number 145287A. A number of patches leaking Fentanyl have been found in this lot that was shipped to consumers between April 2, 2009 and May 20, 2009. Direct contact with Fentanyl gel from a leaking patch can cause serious injury or death. The recalled patches have expiration dates of February 2011 and were manufactured by Watson Laboratories, Inc. and distributed by Watson Pharma, Inc.

December 31, 2008 - Pricara, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., has recalled one lot of 50mcg/hr DURAGESIC® fentanyl patches with the lot number 0817239 and one lot of fentanyl patches sold by Sandoz Inc. with the lot number 0816851. Due to a manufacturing defect these lots may have a "cut" along one side of the patch. The result is a possible release of fentanyl gel from the patch, exposing patients or caregivers directly to the fentanyl gel causing serious injury or death.

On February 17, 2004, Janssen Pharmaceutica Products LP ("Janssen") issued, with the approval of the U.S. Food & Drug Administration (FDA) a Class I Recall of all units of its 75mcg/hr Duragesic® product bearing a specific lot number. Later on April 5, 2004, Janssen issued another urgent recall to include additional lot numbers that also may have contained defective Duragesic® patches. That product is manufactured for Janssen by Alza Corporation ("alza"). Both Janssen and Alza are wholly owned subsidiary companies of Johnson & Johnson.

Duragesic®, known as a "pain patch," is an adhesive patch applied to the tothe skin which is intended to deliver a steady dose of a powerful opioid pain medication (fentanyl) through the skin over an extended time to persons suffering from chronic and/or debilitating pain.

The fentanyl recall itself applies only to specific manufacturing lots of the 75mcg strength product, which (according to recall notices) were designed with a faulty seal which permits full strength fentanyl to leak from the patch delivery system. If the leakage occurs while the patch is on the skin, patients arepotentially caused to suffer an overdose of fentanyl which can result in fatal respiratory and/or cardiac arrest or other, serious physical reactions. The Duragesic® Patch litigation in which MacDonald Rothweiler Eisenberg LLP has taken a leading role, involves re-called patches and other Duragesic patches that are suspected of leaking fentanyl leading to the death of our clients due to "fentanyl toxicity." This may lead to a Duragesic lawsuit.

The lot number of the can be identified by its NDC number and Lot Control Number as follows:

NDC no. 50458-035-05

Lot Control nos. 0327192, 0327193, 0327294, 0327295, and 0330362

To determine whether your Duragesic® product is subject to this recall, please review these Duragesic® photos provided by Janssen to the FDA, which will direct you to the proper place to look for your Lot Control Number. If you cannot read the numbers accurately, a fentanyl patch attorney in our office may be able to better assist you.

If you or a loved one has suffered a catastrophic injury, which you believe is related to your use of a defective Duragesic™ patch, contact a Duragesic lawyer at MacDonald Rothweiler Eisenberg, LLP to assess your potential legal claim.